🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to determine whether, in patients wit...
Status
Completed
Location
Cedars-Sinai Heart Institute
Start Date
2017-03-02
Trial ID
NCT02816736
Treatments Being Tested
Sacubitril/Valsartan (SAC/VAL) is a new treatment of congestive heart failu...
Status
Completed
Location
Andalusia Hospitals
Start Date
2018-12-01
Trial ID
NCT03893435
Treatments Being Tested
Black individuals are more likely to have decreased insulin sensitivity whi...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2020-08-15
Trial ID
NCT04055428
The purpose of this study is to determine the effect of sacubitril/valsarta...
Status
Completed
Location
Duke University Medical Center
Start Date
2021-08-06
Trial ID
NCT04883528
Treatments Being Tested
An open label, balanced, randomized, single dose, two treatment, two sequen...
Status
Completed
Location
Veeda Clinical Research Ltd.
Start Date
2024-12-28
Trial ID
NCT06922253
Treatments Being Tested
The two primary goals of it's management are preventing further disease pro...
Status
Completed
Location
Doctors hospital and medical center
Start Date
2019-01-01
Trial ID
NCT04218435
Treatments Being Tested
The purpose of this study was to investigate the effects of initiation of s...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-12-16
Trial ID
NCT02970669
The purpose of this study is to evaluate the efficacy and safety of LCZ696 ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-12-09
Trial ID
NCT02924727
The purpose of this study is to compare changes in cardiac structure and fu...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2025-02-03
Trial ID
NCT06693674
Treatments Being Tested
The primary objective is to examine the impact of the Renin-Angiotensin-Ald...
Status
Active Not Recruiting
Location
The Ohio State University Wexner Medical Center
Start Date
2020-02-25
Trial ID
NCT03938389
Treatments Being Tested